Package 49609-101-01

{"route": ["INTRAVENOUS"], "spl_id": "43f8e45a-9c5d-81fa-e063-6394a90acbf4", "openfda": {"nui": ["N0000177914", "N0000000205"], "unii": ["0Z5B2CJX4D"], "spl_set_id": ["2028be0c-333c-4e0c-be57-099276c725d7"], "pharm_class_epc": ["Radioactive Diagnostic Agent [EPC]"], "pharm_class_moa": ["Radiopharmaceutical Activity [MoA]"], "manufacturer_name": ["SOFIE Co."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 mL in 1 VIAL, MULTI-DOSE (49609-101-01)", "package_ndc": "49609-101-01", "marketing_start_date": "20111208"}, {"sample": false, "description": "50 mL in 1 VIAL, MULTI-DOSE (49609-101-02)", "package_ndc": "49609-101-02", "marketing_start_date": "20111208"}], "brand_name": "Fludeoxyglucose F 18", "product_id": "49609-101_43f8e45a-9c5d-81fa-e063-6394a90acbf4", "dosage_form": "INJECTION", "pharm_class": ["Radioactive Diagnostic Agent [EPC]", "Radiopharmaceutical Activity [MoA]"], "product_ndc": "49609-101", "generic_name": "Fludeoxyglucose F-18", "labeler_name": "SOFIE Co.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fludeoxyglucose F 18", "active_ingredients": [{"name": "FLUDEOXYGLUCOSE F-18", "strength": "300 mCi/mL"}], "application_number": "ANDA203591", "marketing_category": "ANDA", "marketing_start_date": "20111208", "listing_expiration_date": "20261231"}